Risk of hepatitis B reactivation and cytomegalovirus...

  • Main
  • 2020 / 10
  • Risk of hepatitis B reactivation and cytomegalovirus...
EClinicalMedicine 2020 / 10

Risk of hepatitis B reactivation and cytomegalovirus related infections with Mogamulizumab: A retrospective study of international pharmacovigilance database

Wang, Shuai, Jayarangaiah, Apoorva, Malone, Mariuxi, Elrafei, Tarek, Steinberg, Lewis, Kumar, Abhishek
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
EClinicalMedicine
DOI:
10.1016/j.eclinm.2020.100601
Date:
October, 2020
File:
PDF, 344 KB
2020
Conversion to is in progress
Conversion to is failed